Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1993]
News [3243]
Articles [134]
Editorials [3]
Conferences [122]
elearning [18]
Expert overview on the recent developments in mantle cell lymphoma
Professor Gordon McVie and Professor Simon Rule
Expert overview on the recent developments in mantle cell lymphoma ( Professor Gordon McVie and Professor Simon Rule )
12 Jun 2015
New dexamethasone combination yields two-fold improvement in median PFS in...
Prof Meletios Dimopoulos - University of Athens, Athens, Greece
New dexamethasone combination yields two-fold improvement in median PFS in multiple myeloma ( Prof Meletios Dimopoulos - University of Athens, Athens, Greece )
5 Jun 2015
ASCO 2015: Latest developments in multiple myeloma
Prof Philippe Moreau, Prof Sagar Lonial, Prof Meletios Dimopoulos
ASCO 2015: Latest developments in multiple myeloma ( Prof Philippe Moreau, Prof Sagar Lonial, Prof Meletios Dimopoulos )
1 Jun 2015
ASCO 2015: Latest in chronic lymphocytic leukaemia
Prof Stephan Stilgenbauer and Dr Jacqueline Barrientos
ASCO 2015: Latest in chronic lymphocytic leukaemia ( Prof Stephan Stilgenbauer and Dr Jacqueline Barrientos )
1 Jun 2015
Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia...
Dr William Slayton - University of Florida, Gainsville, USA
Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia chromosome positive ALL ( Dr William Slayton - University of Florida, Gainsville, USA )
1 Jun 2015
Improved care has extended lifespan of childhood cancer survivors since the...
Dr Gregory Armstrong - St Jude Children’s Research Hospital, Mempis, USA
Improved care has extended lifespan of childhood cancer survivors since the 1970s ( Dr Gregory Armstrong - St Jude Children’s Research Hospital, Mempis, USA )
31 May 2015
Improved care has extended lifespan of childhood cancer survivors since the...
Dr Gregory Armstrong - St Jude Children’s Research Hospital, Mempis, USA
Improved care has extended lifespan of childhood cancer survivors since the 1970s ( Dr Gregory Armstrong - St Jude Children’s Research Hospital, Mempis, USA )
31 May 2015
New targeted treatments for blood cancers: Multiple myeloma, non-Hodgkin...
Dr Merry-Jennifer Markham - University of Florida, Florida, USA
New targeted treatments for blood cancers: Multiple myeloma, non-Hodgkin lymphoma, genomic marker mismatch repair and myelofibrosis ( Dr Merry-Jennifer Markham - University of Florida, Florida, USA )
30 May 2015
Targeted drug daratumumab shows promise in heavily treatment-resistant multiple...
Dr Saad Zafar Usmani - Levine Cancer Institute, Charlotte, USA
Targeted drug daratumumab shows promise in heavily treatment-resistant multiple myeloma ( Dr Saad Zafar Usmani - Levine Cancer Institute, Charlotte, USA )
30 May 2015
Ibrutinib combination regimen shows substantial benefits in relapsed CLL
Dr Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA
Ibrutinib combination regimen shows substantial benefits in relapsed CLL ( Dr Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA )
30 May 2015
Novel JAK inhibitor pacritinib proves effective for easing symptoms of...
Dr Ruben Mesa - Mayo Clinic Cancer Center, Scottsdale, USA
Novel JAK inhibitor pacritinib proves effective for easing symptoms of myelofibrosis ( Dr Ruben Mesa - Mayo Clinic Cancer Center, Scottsdale, USA )
30 May 2015
New ibrutinib combination regimen shows substantial benefits in relapsed...
Prof Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA
New ibrutinib combination regimen shows substantial benefits in relapsed chronic lymphocytic leukaemia ( Prof Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA )
30 May 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation